Jump to content

ICRF 193: Difference between revisions

Page 1
Page 2
Content deleted Content added
Script assisted update of identifiers from ChemSpider, CommonChemistry and FDA for the Chem/Drugbox validation project - Updated: ChEMBL.
OAbot (talk | contribs)
m Open access bot: doi added to citation with #oabot.
 
(11 intermediate revisions by 10 users not shown)
Line 1: Line 1:
{{chembox
{{chembox
| verifiedrevid = 400113711
| verifiedrevid = 415659765
|ImageFile=ICRF 193.png
| ImageFile=ICRF 193.png
|ImageSize=200px
| ImageSize=200px
|IUPACName=4-[2-(3,5-Dioxo-1-piperazinyl)-1-methylpropyl]piperazine-2,6-dione
| IUPACName=4-[2-(3,5-Dioxo-1-piperazinyl)-1-methylpropyl]piperazine-2,6-dione
|OtherNames=
| OtherNames=
|Section1={{Chembox Identifiers
|Section1={{Chembox Identifiers
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 103034
| ChemSpiderID = 103034
| InChI = 1/C12H18N4O4/c1-7(15-3-9(17)13-10(18)4-15)8(2)16-5-11(19)14-12(20)6-16/h7-8H,3-6H2,1-2H3,(H,13,17,18)(H,14,19,20)
| InChI = 1/C12H18N4O4/c1-7(15-3-9(17)13-10(18)4-15)8(2)16-5-11(19)14-12(20)6-16/h7-8H,3-6H2,1-2H3,(H,13,17,18)(H,14,19,20)
| InChIKey = OBYGAPWKTPDTAS-UHFFFAOYAB
| InChIKey = OBYGAPWKTPDTAS-UHFFFAOYAB
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 275665
| ChEMBL = 275665
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
Line 15: Line 16:
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = OBYGAPWKTPDTAS-UHFFFAOYSA-N
| StdInChIKey = OBYGAPWKTPDTAS-UHFFFAOYSA-N
| CASNo_Ref = {{cascite|correct|??}}
| CASNo=21416-68-2
| CASNo=21416-68-2
| PubChem=115150
| PubChem=115150
| SMILES = O=C2NC(=O)CN(C(C(N1CC(=O)NC(=O)C1)C)C)C2
| SMILES = O=C2NC(=O)CN(C(C(N1CC(=O)NC(=O)C1)C)C)C2
| MeSHName=ICRF+193
| MeSHName=ICRF+193
}}
}}
|Section2={{Chembox Properties
|Section2={{Chembox Properties
| Formula=C<sub>12</sub>H<sub>18</sub>N<sub>4</sub>O<sub>4</sub>
| Formula=C<sub>12</sub>H<sub>18</sub>N<sub>4</sub>O<sub>4</sub>
| MolarMass=282.30 g/mol
| MolarMass=282.30 g/mol
| Appearance=
| Appearance=
| Density=
| Density=
| MeltingPt=
| MeltingPt=
| BoilingPt=
| BoilingPt=
| Solubility=
| Solubility=
}}
}}
|Section3={{Chembox Hazards
|Section3={{Chembox Hazards
| MainHazards=
| MainHazards=
| FlashPt=
| FlashPt=
| AutoignitionPt =
| Autoignition=
}}
}}
}}
}}


'''ICRF 193''' is a [[topoisomerase inhibitor]].<ref name="pmid17495539">{{cite journal |author=Robinson HM, Bratlie-Thoresen S, Brown R, Gillespie DA |title=Chk1 is required for G2/M checkpoint response induced by the catalytic topoisomerase II inhibitor ICRF-193 |journal=Cell Cycle |volume=6 |issue=10 |pages=1265–7 |year=2007 |month=May |pmid=17495539 |doi= |url=http://www.landesbioscience.com/journals/cc/abstract.php?id=4225}}</ref>
'''ICRF 193''' is a [[topoisomerase inhibitor]].<ref name="pmid17495539">{{cite journal |vauthors=Robinson HM, Bratlie-Thoresen S, Brown R, Gillespie DA |title=Chk1 is required for G2/M checkpoint response induced by the catalytic topoisomerase II inhibitor ICRF-193 |journal=Cell Cycle |volume=6 |issue=10 |pages=1265–7 |date=May 2007 |pmid=17495539 |doi= 10.4161/cc.6.10.4225|url=http://www.landesbioscience.com/journals/cc/abstract.php?id=4225|doi-access=free }}</ref>


==References==
==References==
Line 42: Line 44:


[[Category:Imides]]
[[Category:Imides]]
[[Category:Piperazines]]
[[Category:Diketopiperazines]]
[[Category:Lactams]]
[[Category:Topoisomerase inhibitors]]



{{organic-compound-stub}}
{{organic-compound-stub}}

[[sr:ICRF 193]]